Light as a Biological Language: How Cells “Read” the Light Spectrum and Respond

Light is often understood in simple terms: brightness, colour or energy reaching the surface of the body. That may be sufficient for ordinary lighting. It is not sufficient for photobiomodulation.

Living tissue is not a passive surface. It reflects, absorbs and scatters light, and the resulting interaction depends on tissue composition and biological state. The body therefore does not respond to every wavelength in the same way, and a number measured in nanometres does not by itself describe the biological exposure.

This is why the metaphor of light as a biological language is useful. Wavelength represents one element of the information, dose provides structure, and tissue is the receiver. The metaphor has limits — cells do not literally read nanometres as humans read words — but it captures an important principle: different physical light exposures create different conditions for biological responses.

LIGHT IS MORE THAN ENERGY. IT IS BIOLOGICAL INFORMATION.

A common oversimplification in red light therapy is the idea that light simply gives cells energy. Cellular energetics, however, emerge from complex metabolic processes involving mitochondria, oxygen, enzymes, redox conditions, nutrients, microcirculation and many other factors.

Light does not replace those processes. It can become one input within them.

PBM research therefore examines not only optical absorption but also how an optical stimulus may influence mitochondrial signalling, nitric oxide, ATP, redox pathways, calcium and other regulatory mechanisms.

The biological result is not produced by the panel.

It is produced by the organism.

SPECTRUM AS LANGUAGE: WHY THE BODY DOES NOT RESPOND TO EVERY WAVELENGTH IN THE SAME WAY

The light spectrum is not neutral to tissue. Different wavelengths differ in the way they are absorbed, scattered, reflected and transmitted through biological structures.

Photobiomodulation frequently uses red wavelengths around 630, 660 or 670 nm and NIR wavelengths around 810, 830 or 850 nm. These values are not magic prescriptions. Their biological meaning depends on the complete optical exposure.

In general, shorter red wavelengths are more strongly attenuated in superficial tissues, whereas NIR may under suitable conditions penetrate more deeply. Contemporary PBM reviews emphasise that wavelength influences anatomical energy distribution while target-tissue composition and dose remain equally important.

This does not mean RED belongs only to skin and NIR only to muscle or joints. Human tissue contains melanin, blood, water, adipose tissue and connective structures, all of which influence optical propagation.

Spectrum is therefore not a list of nanometres.

It is an architecture.

CELLS DO MORE THAN ABSORB LIGHT. THEY RESPOND TO THE INTERACTION.

Physical absorption is necessary, but it is not the end of the story. When an appropriate optical input interacts with biologically relevant structures, changes in cellular signalling may follow.

PBM research discusses mitochondrial pathways, cytochrome c oxidase, nitric oxide, ATP, redox signalling, ROS, ion channels and calcium.

This does not mean that a photon mechanically switches a cell into a recovery mode. A more accurate description is that a physical optical input may alter the regulatory environment of the cell, and the cell responds according to its current biological state.

The statement “light works” is therefore incomplete.

A better question is: what is the state of the tissue receiving the signal?

DOSE IS THE GRAMMAR OF LIGHT

A language requires more than vocabulary. It requires grammar. In PBM, that grammar is not a single number but the complete dosing arrangement.

Knowing that a device contains 660 or 850 nm is not enough. Irradiance, exposure duration, working distance, illuminated area, optics and frequency all matter.

PBM can also demonstrate a nonlinear dose response. An exposure that is too low may be insufficient, an appropriate range may be biologically relevant, and excessive exposure may not provide additional benefit.

This is why TANVEA rejects the assumption that more is automatically better.

The body needs an appropriate, readable signal.

DISTANCE CHANGES MORE THAN INTENSITY

Working distance is often treated simply as a way of controlling intensity. In a real LED array, it also changes the size of the illuminated field, the overlap between individual beams, spatial uniformity and — in multi-wavelength systems — the way different spectral channels mix at the body surface.

Working distance is therefore part of optical architecture, not a minor user setting.

This will also be important in the future technical discussion of mono-chip versus dual-chip designs. Biological tissue does not respond to the number of semiconductor chips hidden beneath a lens. It responds to the resulting optical field reaching the body.

WHY THE SAME LIGHT DOES NOT PRODUCE THE SAME RESPONSE

Two people can use the same panel, at the same distance, for the same duration and still respond differently.

Skin pigmentation, tissue thickness, perfusion, hydration, oxygen availability, metabolic state, sleep, inflammatory conditions, previous exercise and autonomic regulation may all contribute.

This does not make photobiomodulation unpredictable. It means that the human body is not a standardised laboratory detector.

The device creates the physical exposure.

The organism creates the biological response.

CREATING A BIOLOGICAL CONTEXT FOR THE LIGHT SIGNAL

If light is understood as biological information, it makes sense to think about the environment receiving that information. This does not mean every red light session must follow another therapy or that there is one mandatory TANVEA ritual.

It means tissue behaves differently depending on perfusion, hydration, metabolism and oxygen availability. Circulation affects transport, mitochondria require oxygen for oxidative metabolism, and autonomic regulation influences vascular and metabolic conditions.

TANVEA therefore does not view Light Systems™ in isolation. Not because other modalities automatically amplify PBM, but because every optical stimulus enters an already existing biological environment.

LIGHT WITHIN TANVEA BIOLOGICAL SYSTEMS™

Hydro Systems™ represent water, pressure, buoyancy and flow. Thermal Systems™ represent thermal exposure and thermoregulatory response. Light Systems™ represent spectrally and dosimetrically defined optical input. Oxygen Systems™ represent oxygen availability and energetic context. Hydrogen Systems™ represent the separate field of molecular hydrogen and redox research.

This is not a claim that every system must always be used together.

It is systems thinking.

The human body is not a collection of isolated cells, and light does not enter a biological vacuum.

WHY TANVEA LIGHT SYSTEMS™ ARE MORE THAN PANEL POWER

The conventional market communicates through more LEDs, more power, more wavelengths and higher irradiance. Each can be technically relevant, but none alone defines the biological quality of exposure.

TANVEA therefore approaches Light Systems™ as optical architecture. Spectrum, output of individual channels, optics, beam angle, LED placement, distance, field uniformity, illuminated area and exposure duration together determine what the body actually receives.

We do not ask only how many wavelengths a panel contains.

We ask what they create together.

We do not ask only for a peak measurement at one point.

We ask what exposure a real area of the body receives.

That is where a product begins to become a system.

WHERE THE METAPHOR ENDS AND RESPONSIBILITY BEGINS

The metaphor of light as language is useful but must remain scientifically disciplined. Cells do not literally read nanometres as people read words.

A more accurate statement is:

Light is a physical stimulus that a living organism may biologically interpret.

That preserves the idea without exceeding the evidence.

Responsible use matters just as much. More powerful light is not automatically better, longer exposure is not automatically more effective, and direct staring into intense LED arrays is not a requirement of PBM. Photosensitivity, photosensitising medication, certain eye conditions and significant health problems warrant individual caution.

CONCLUSION: SPECTRUM IS NOT A LIST OF NANOMETRES

Light is more than power, colour or a number in nanometres.

Its biological meaning emerges from the interaction of wavelength, dose, optics, geometry, target tissue and biological state.

Red and NIR light should therefore not be treated as simple switches assigned to individual effects. They are different regions of the electromagnetic spectrum with different optical characteristics that can, under appropriate conditions, participate in biological responses.

TANVEA Light Systems™ therefore do not build spectral architecture around the question:

How many wavelengths can we add?

We ask:

How can we create an optical stimulus that is physically precise, biologically meaningful and reproducible?

Not the most complicated.

But readable.

---

FAQ

What does it mean to call light a biological language?
It is a metaphor describing the fact that different optical exposures can create different biological conditions and responses.

What is the difference between red and NIR light?
They differ primarily in optical behaviour within tissue. NIR can, under certain conditions, penetrate more deeply.

Is 850 nm better than 660 nm?
There is no universally better wavelength. The answer depends on target tissue, dose and the complete system.

Are more wavelengths automatically better?
No. Their role, ratio, output and resulting spectral field matter more than wavelength count.

Why does working distance matter?
Because it affects irradiance, field size, uniformity and spectral overlap.

Is deeper penetration always better?
No. Appropriate exposure of the target tissue matters more than maximum depth.

---

SCIENTIFIC SOURCES

de Freitas LF, Hamblin MR. 2016.
Hamblin MR. 2018.
Huang YY et al. 2011.
Zein R, Selting W, Hamblin MR. 2018.
Arany PR. Photobiomodulation therapy. 2025.
Maghfour J et al. Evidence-based consensus on the clinical application of photobiomodulation. 2025.